Methods | D: crossover C: unclear B: double WD: 6/18 J: 1‐1‐1 DU: 1m/2x3m (2w)/‐ | |
Participants | N: 18/12 D: all migraine without aura C: Ad Hoc F: 89% A: 18‐49 years DU: 3‐38 years S: probably neurological university outpatient clinic in Italy | |
Interventions | P: 1.8 mg/kg C: Acetylsalicylic acid 13.5 mg/kg | |
Outcomes | R: 9/12 vs. 9/12 (at least 50% index reduction) F: not reported AU: not reported HI: 65% reduction in both groups AEs: 6/12 vs. 6/12 Dropouts‐AEs: 2/18 vs. 3/18 V: 0 | |
Notes | Small trial with relatively high dropout rate | |
Risk of bias | ||
Bias | Authors' judgement | Support for judgement |
Allocation concealment (selection bias) | Unclear risk | B ‐ Unclear |